Correlation Engine 2.0
Clear Search sequence regions


  • estrous cycle (1)
  • estrus (1)
  • female (1)
  • humans (1)
  • hyperandrogenemia (2)
  • hyperinsulinemia (1)
  • insulin (1)
  • lipid (1)
  • mice (3)
  • mice obese (1)
  • oocytes (8)
  • ovary (2)
  • PCOS (5)
  • research (1)
  • rna (1)
  • weight (1)
  • Sizes of these terms reflect their relevance to your search.

    Hyperandrogenemia in an obese PCOS mouse model results in altered glucose/insulin metabolism and mitochondrial structure and function in the oocytes, in part explaining adverse outcomes and inheritance patterns seen in PCOS. To study the oocyte quality by means of mitochondrial structure and function in a well-established classic PCOS mouse model. Animal study using an obese PCOS mouse model compared with control. Animal research facility in a tertiary care university hospital setting. C57/B6J mice. Three week old mice had subdermal implants of DHT controlled release pellet or placebo for 90 days. The mouse model was validated by performing glucose tolerance test, HbA1c levels, body weight and estrous cycle analyses. Oocytes were subsequently isolated and were used to investigate mitochondrial membrane potential, oxidative stress, lipid peroxidation, ATP production, mtDNA copy number, transcript abundance, histology and electron microscopy. Results showed glucose intolerance and hyperinsulinemia along with dysregulated estrus cycle. Analysis of the oocytes demonstrated impaired inner mitochondrial membrane function, increased ATP production and mtDNA copy number, altered RNA transcript abundance and aberrant ovarian histology. Electron microscopy of the oocytes showed severely impaired mitochondrial ultrastructure. The obese PCOS mouse model shows a decreased oocyte quality related to impaired mitochondrial function.

    Citation

    Neil R Chappell, Beth Zhou, Pardis Hosseinzadeh, Amy Schutt, William E Gibbons, Chellakkan S Blesson. Hyperandrogenemia alters mitochondrial structure and function in the oocytes of obese mouse with polycystic ovary syndrome. F&S science. 2021 Feb;2(1):101-112

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 34458875

    View Full Text